Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

FDA approves revised labeling for Flonase

May 14, 2003

Enanta claims new ciclosporin analogues with utility in asthma therapy

May 12, 2003

Abgenix and Sosei enter CRTH2-targeting antibody development agreement

May 12, 2003

PDL discontinues development of anti-IL-4 antibody for asthma

May 12, 2003

Novel chemokine CCR2 antagonists in UCB pipeline

May 9, 2003

Potential use of GERD medications as adjunctive therapy in asthma

May 6, 2003

Dual CCR3 modulators/H1 antagonists identified by AstraZeneca researchers

April 30, 2003

Nippon Boehringer Ingelheim and Sankyo intend to comarket Alesion

April 29, 2003

Indole-based prostanoid DP receptor antagonists newly discovered at Ono

April 29, 2003

BMS researchers design novel chemokine CCR3 receptor modulators

April 29, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...